Quest Diagnostics (DGX) PT Raised to $100 at Barclays Following 1Q Report; Best Headline Growth in 2 Years
Tweet Send to a Friend
Barclays raised its price target on Quest Diagnostics (NYSE: DGX) to $100.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
